C&D’s Act May Be Hard To Follow For Drug Firms Considering Bolt-Ons
This article was originally published in The Tan Sheet
Executive Summary
Church & Dwight CEO James Craigie has a few words of wisdom on bolt-on acquisitions, recently a popular buzzword among big pharmas looking for savings
You may also be interested in...
Church & Dwight divests brands
Langhorne, Pa.-based Insight Pharmaceuticals looks to strengthen its OTC drug position with the purchase of seven brands from Church & Dwight - Auro-Dri, Boil Ease, Dermarest, Gentle Naturals, Pronto, Skin Shield and Stye - the company announces June 17. C&D acquired the brands as part of its purchase of Del Labs from Coty last year, an acquisition it made to obtain the Orajel brand. The divestiture is in line with C&D's strategy of making bolt-on acquisitions and discarding underperforming assets (1"The Tan Sheet" April 6, 2009)
Church & Dwight divests brands
Langhorne, Pa.-based Insight Pharmaceuticals looks to strengthen its OTC drug position with the purchase of seven brands from Church & Dwight - Auro-Dri, Boil Ease, Dermarest, Gentle Naturals, Pronto, Skin Shield and Stye - the company announces June 17. C&D acquired the brands as part of its purchase of Del Labs from Coty last year, an acquisition it made to obtain the Orajel brand. The divestiture is in line with C&D's strategy of making bolt-on acquisitions and discarding underperforming assets (1"The Tan Sheet" April 6, 2009)
Church & Dwight divests brands
Langhorne, Pa.-based Insight Pharmaceuticals looks to strengthen its OTC drug position with the purchase of seven brands from Church & Dwight - Auro-Dri, Boil Ease, Dermarest, Gentle Naturals, Pronto, Skin Shield and Stye - the company announces June 17. C&D acquired the brands as part of its purchase of Del Labs from Coty last year, an acquisition it made to obtain the Orajel brand. The divestiture is in line with C&D's strategy of making bolt-on acquisitions and discarding underperforming assets (1"The Tan Sheet" April 6, 2009)